| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/26/2007 | CN101041816A Artificial antigen submit cell and preparation method thereof |
| 09/26/2007 | CN101041815A Soluble CD40L stimulation human peripheral blood B cell long-period culture method |
| 09/26/2007 | CN101041814A Magnetic nano cell automatic sorting device and uses thereof |
| 09/26/2007 | CN101041696A Preparation method of heavy metallic lead resistant monoclonal antibody |
| 09/26/2007 | CN101041694A Angiogenin-like protein V and preparation method thereof, its polyclonal antibody and uses thereof |
| 09/26/2007 | CN101041690A Recombinant dog hookworm coagulate peptide resistant 5 mutant, its encoding gene, preparation and application thereof |
| 09/26/2007 | CN101041680A Nucleic acid molecule RTN4BSR6 and application for preparation of anti-cancer drugs |
| 09/26/2007 | CN101040602A Quick propagating method of blumea riparia(Bl.)DC medicine material |
| 09/26/2007 | CN101040601A Method and technique of the separated tissue culture of Kava |
| 09/26/2007 | CN101040600A Method of crossbreeding and quick propagating the lilium formolongi seed and its parents |
| 09/26/2007 | CN100339479C Gene participating in the synthesis of brassinosteroid |
| 09/26/2007 | CN100339477C Methods and devices for tissure repair |
| 09/26/2007 | CN100339476C Hot pepper free spore cell assemblies culture method |
| 09/26/2007 | CN100339395C E type hepatitis virus monoclonal antibody or its conjugated active fragment and use thereof |
| 09/26/2007 | CN100338998C Method for culturing embryoid of woody plant anther |
| 09/26/2007 | CN100338989C Method and system for producing manufactured seeds |
| 09/25/2007 | US7273975 Inbred maize line PHB6V |
| 09/25/2007 | US7273974 Inbred corn line G0805 |
| 09/25/2007 | US7273973 Inbred corn line PHEHG |
| 09/25/2007 | US7273972 Seed comprising chromosomes of maize inbred line PH3RC; introducing trait of waxy starch, male sterility; herbicide, insect, bacterial disease, fungal disease, and viral disease resistance; hybrids; genetic engineering; restriction fragment length polymorphism enhanced selection |
| 09/25/2007 | US7273971 Inbred maize line PH1GD |
| 09/25/2007 | US7273970 Inbred corn line BE1146BMR |
| 09/25/2007 | US7273966 Expression vector coding multifunctional enzymatic polypeptide for generation and propagation of plants comprising tissues with increased fatty acid biosynthesis; enhancing nutrient quality of plants |
| 09/25/2007 | US7273964 Non-human transgenic animals for the study of neurodegenerative syndromes |
| 09/25/2007 | US7273932 Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use |
| 09/25/2007 | US7273931 Plant promoter |
| 09/25/2007 | US7273929 B1k chain of laminin and methods of use |
| 09/25/2007 | US7273928 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 09/25/2007 | US7273926 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
| 09/25/2007 | US7273925 Methods and products for regulating lectin complement pathway associated complement activation |
| 09/25/2007 | US7273855 Single stranded oligonucleotides of DNA or RNA, particularly RNA transcribed from portions of wild type prohibitin 3'UTR, into tumors leads to arrested cell proliferation. Significant reduction in the size of primary tumors has been observed |
| 09/25/2007 | US7273758 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 09/25/2007 | US7273756 Culturing a population of chondrocytes on a substrate in a culture medium, wherein the substrate comprises polystyrene and hyaluronic acid which are covalently bound to each other, wherein the population of chondrocytes can undergo 3.8 doublings while at least 50% of the cells retain rounded morphology |
| 09/25/2007 | US7273755 Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds |
| 09/25/2007 | US7273754 Core 1 β3-galactosyltransferase specific molecular chaperones, nucleic acids, and methods of use thereof |
| 09/25/2007 | US7273753 Comprises separation via anti-CD2 antibodies/stimulation of interleukin production; vaccines; immunotherapy; anticancer agents |
| 09/25/2007 | US7273752 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 09/25/2007 | US7273751 Comprises nucleotide sequences associated with expression vector coding endothelial growth factor for use in diagnosis and treatment of tumor angiogenesis, inflammation, diabetic retinopathy, arthritis and psoriasis; wound healing agent |
| 09/25/2007 | US7273744 Heparanase-like polypeptides |
| 09/25/2007 | US7273743 Comprises genetically engineered beta-site amyloid precursor protein-cleaving enzyme (BACE) for prevention, diagnosis and treatment of neurodegenerative and alzheimer's diseases |
| 09/25/2007 | US7273742 BGL3 beta-glucosidase and nucleic acids encoding the same |
| 09/25/2007 | US7273740 Enzymes having alpha amylase activity and methods of use thereof |
| 09/25/2007 | US7273739 Claimed are specific enzymes having strand cleavage activity, 3' to 5' exonuclease activity, and polymerase activity that are combined with a heteroduplex polynucleotide to increased complementarity within the heteroduplex |
| 09/25/2007 | US7273737 Comprises nucleotide sequences coding synthases for enhancing isoprenoid biosynthesis, herbicide screening and crop defense and protection |
| 09/25/2007 | US7273735 Making valencene by contacting farnesyl-pyrophosphate with a valencene synthase that has been encoded by a nucleic acid with a specific sequence, especially from grapefruit |
| 09/25/2007 | US7273729 Chondroitin synthase and DNA encoding the enzyme |
| 09/25/2007 | US7273727 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence |
| 09/25/2007 | US7273723 A system for antibiotic-regulated gene expression in eukaryotic cells, based on sequences from Enterobacteriaceae antibiotic resistance promoters, polypeptides that bind to the same in an antibiotic- responsive manner |
| 09/25/2007 | US7273722 Insertion of cleavage sites in non-critical regions of the toxins which are susceptible to protease activity in non-target tissues and single chain forms activated by proteases in the target; botulism and tetanus toxins; confine activity to target site; side effect reduction |
| 09/25/2007 | US7273694 Method and apparatus for reducing pathogens in a biological sample |
| 09/25/2007 | US7273612 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/25/2007 | US7273610 Endotheliase-2 ligands |
| 09/25/2007 | CA2294649C Bovine adenovirus type 3 genome |
| 09/25/2007 | CA2214018C An immortalized mammal hybridoma fusion partner |
| 09/25/2007 | CA2192442C Complementary adenoviral vector systems and cell lines |
| 09/25/2007 | CA2173592C Stem cell proliferation factor |
| 09/25/2007 | CA2132868C Method of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells |
| 09/22/2007 | CA2582272A1 System for regulated and enhanced baculovirus mediated transient transgene expression in mammalian cells |
| 09/20/2007 | WO2007106905A2 Polyunsaturated fatty acid production in heterologous organisms using pufa polyketide synthase systems |
| 09/20/2007 | WO2007106904A2 Plant seed oils containing polyunsaturated fatty acids |
| 09/20/2007 | WO2007106903A2 Polyunsaturated fatty acid production in heterologous organisms using pufa polyketide synthase systems |
| 09/20/2007 | WO2007106868A2 Cell culture devices having ultrathin porous membrane and uses thereof |
| 09/20/2007 | WO2007106728A2 Soybean seed and oil compositions and methods of making same |
| 09/20/2007 | WO2007106596A2 Human liver cancer cell line |
| 09/20/2007 | WO2007106575A2 Automatable artificial immune system (ais) |
| 09/20/2007 | WO2007106559A2 An in vitro mucosal tissue equivalent |
| 09/20/2007 | WO2007106545A2 Propagation of primary cells |
| 09/20/2007 | WO2007106497A2 Three-dimensional fabrication of biocompatible structures in anatomical shapes and dimensions for tissue engineering and organ replacement |
| 09/20/2007 | WO2007106200A2 Expansion and differentiation of neural stem cells under low oxygen conditions |
| 09/20/2007 | WO2007105797A1 Novel human t cell population |
| 09/20/2007 | WO2007105744A1 Purkinje cell-tropic viral vector |
| 09/20/2007 | WO2007105565A1 Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza |
| 09/20/2007 | WO2007104979A1 Virus-like particles of rift valley fever virus |
| 09/20/2007 | WO2007104715A2 Specific cd4+cd25+ regulatory t cells for haematopoietic cell transplantation and immune tolerance |
| 09/20/2007 | WO2007067460A8 Manipulation of biological species using magnetic field modulators |
| 09/20/2007 | WO2007063311A3 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007063308A3 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007041513A3 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 09/20/2007 | WO2007038029A3 Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof |
| 09/20/2007 | WO2007027315A3 A biological bypass bridge with sodium channels, calcium channels and/or potassium channels to compensate for conduction block in the heart |
| 09/20/2007 | WO2006025059A3 Salt resistant transgenic plants |
| 09/20/2007 | WO2005011590A3 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 09/20/2007 | WO2004004649A3 Compositions and methods for the treatment of immune related diseases |
| 09/20/2007 | US20070220635 Catalyses the 2 beta -oxidation of a gibberellin molecule to introduce a hydroxyl group at C-2 and further catalyses the oxidation of the hydroxyl group introduced at C-2 to yield the ketone derivative; transgenic plants with improved or altered growth characteristics; agriculture; horticulture |
| 09/20/2007 | US20070220634 Plant seed oils containing polyunsaturated fatty acids |
| 09/20/2007 | US20070220633 Comprises a cDNA sequence reverse transcribed from RNA of Cymbidium mosaic virus (CymMV); Virus induced gene silencing; viral vector whose transcripts induce gene inactivation in an orchid |
| 09/20/2007 | US20070220632 Cotton Cultivar PM 3225 B2RF |
| 09/20/2007 | US20070220631 Cotton Cultivar 06W650F |
| 09/20/2007 | US20070220630 Cotton Cultivar DP 121 RF |
| 09/20/2007 | US20070220629 transgenic plant having increased resistance to a picolinate auxin herbicide; has inhibited expression of the wild-type AFB5 gene |
| 09/20/2007 | US20070220625 Pea cultivar FP2282 |
| 09/20/2007 | US20070220624 Pea cultivar FP2280 |
| 09/20/2007 | US20070220623 Lettuce cultivar 50-0401001-B |
| 09/20/2007 | US20070220622 Nucleic acid molecules and other molecules associated with the cytokinin pathway |
| 09/20/2007 | US20070220621 Genetic characterization and prognostic significance of cancer stem cells in cancer |
| 09/20/2007 | US20070219526 Restenosis Therapy Using Mesenchymal Stem Cells |
| 09/20/2007 | US20070219277 Small molecules used to increase cell death |
| 09/20/2007 | US20070219257 Wnt Pathway Antagonists |
| 09/20/2007 | US20070219157 Complete nutrient medium for use as a cosmetic and cosmetic use thereof |
| 09/20/2007 | US20070219155 Treating trinucleotide repeat conditions |